N-acetylmuramic acid recognition by MurK kinase from the MurNAc auxotrophic oral pathogen Tannerella forsythia

Aleksandra Cecylia Stasiak1, Karolin Gogler1, Marina Borisova2

  • 1Interfaculty Institute of Biochemistry, University of Tuebingen, Tuebingen, Germany.

Insights

Tannerella forsythia obtains N-acetylmuramic acid (MurNAc) from its environment. This study reveals crystal structures of MurNAc kinases (MurK and K1058), detailing their active sites and kinetic properties for potential drug development.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Microbiology

Background:

  • The bacterial cell wall's peptidoglycan layer is crucial for structure and integrity.
  • Tannerella forsythia, a pathogen linked to periodontitis, uniquely acquires N-acetylmuramic acid (MurNAc) due to lacking biosynthetic pathways.
  • Sugar kinases are vital for MurNAc recycling by phosphorylating MurNAc.

Purpose of the Study:

  • To elucidate the structural and functional characteristics of MurNAc kinases (MurK and K1058) from Tannerella forsythia.
  • To identify key residues responsible for MurNAc specificity and enzyme activity.
  • To provide a structural basis for developing inhibitors targeting pathogen MurK enzymes.

Main Methods:

  • X-ray crystallography was used to determine the structures of MurK and K1058 in various states (unbound, with AMP-PCP, with MurNAc).
  • Kinetic parameters (Km and Vmax) were measured for both enzymes.
  • Analysis of active site residues was performed to understand MurNAc binding specificity.

Main Results:

  • The crystal structures of MurK and K1058, including complexes with ligands, were determined.
  • Specific active site residues (S133, P134, L135) were identified as crucial for MurNAc specificity in T. forsythia.
  • MurK exhibited significantly higher catalytic activity (Vmax) than K1058, while both showed comparable affinity for MurNAc.

Conclusions:

  • The structural and kinetic data provide insights into the function of MurNAc kinases in T. forsythia.
  • The identified active site features offer a foundation for designing specific inhibitors against MurK enzymes.
  • This research supports a structure-guided strategy for developing novel anti-periodontitis therapeutics targeting bacterial MurNAc metabolism.